In Pilot Study, OICR Aims to Validate PacBio RS for Targeted Sequencing of Cancer Patients
August 03, 2011
In Pilot Study, OICR Aims to Validate PacBio RS for Targeted Sequencing of Cancer Patients
OICR plans to validate the machine and develop a framework for sequencing patient tumors that can help physicians make informed decisions about treatments or clinical trial placements.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- OICR Reports Pilot Data from Clinical Sequencing Study; Switching from PacBio to MiSeq in Second Stage
September 12, 2012 / Clinical Sequencing News - Targeted Sequencing Panels Gaining Ground for Cancer Dx
August 17, 2011 / Clinical Sequencing News - Foundation Medicine Raises $10M, En Route to Launching Targeted Sequencing Test for Cancer Dx
August 24, 2011 / Clinical Sequencing News - Pathogenica Plans 2012 Launch for Sequencing-Based HPV Dx; HIV and HCV Tests in Pipeline
August 17, 2011 / Clinical Sequencing News - Genomic Health Completes Transcriptome Sequencing Study, Files Patents for NGS Library Prep
August 9, 2011 / Clinical Sequencing News